Study to Evaluate Multiple Doses of ERB-041 in Healthy, Female Japanese Subjects

Phase 1 Completed 24 enrolled Wyeth is now a wholly owned subsidiary of Pfizer

RandomizedSingle-groupDouble-blindTreatment

Summary

The primary objective is evaluate the safety, tolerability, and pharmacokinetics of multiple doses of ERB-041, an investigational drug, in healthy, female Japanese subjects.

Timeline

Start: 2006-08
Primary completion: —
Completion: 2006-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	PRINABEREL	Small molecule	—	Oral

Indications

No indication recorded.